IHI-PROMINENT

We are proud to host the third event in the LETHE Project webinar series! The upcoming webinar is titled "Beyond the Hype: AI in Dementia- From Early Risk Detection to Disease Treatment" and will be held on Friday 17th of January from 10.30 to 11.30 am CET.    We will be joined by representatives from the projects The AI-Mind Project, IHI-PROMINENT and ADIS JPND. The webinar will have a look at how AI is being used in dementia, discussing aspects such as digital sleep monitoring, using AI to predict the progression of dementia, and how we can develop an AI-Driven Multidomain Intervention Framework for Mitigating Cognitive Decline in Older Adults. There will be a panel discussion and a chance for audience members to ask their own questions to our speakers. Don't miss out, come and join us! Register for the webinar: https://lnkd.in/dJTF4hVj #dementiaprevention #dementia #alzheimers #AIindementia #LETHE

Only one week until we join the #H2020 LETHE Project webinar "Beyond the hype: AI in dementia – from early risk detection to disease treatment." along with The AI-Mind Project and ADIS JPND. Don't miss it and register now: https://lnkd.in/dJTF4hVj

What are the opportunities and challenges of the new passive anti-amyloid β immunotherapy approaches in Alzheimer's disease? Have a look at the paper of Michael Heneka, Dave Morgan and Frank Jessen recently published in The Lancet. 💊 🧠 With the advent of this disease-modifying therapy, questions arise: Who, when, and how to treat? In this article, the authors discuss recent clinical trial results and review appropriate use recommendations. 🗣️ "In our view, we are experiencing a fundamental shift to early, biomarker-guided treatment of Alzheimer's disease. This shift requires substantial adjustments of infrastructure and resources, but holds promise of eventually achieving substantial slowing of disease progression." 📄 Read the full article: https://lnkd.in/emd7WPiJ

🔬💻 Exciting news! Join us for the LETHE webinar: "Beyond the Hype: AI in Dementia – from Early Risk Detection to Disease Treatment" 📅 When? On 17 January at ⏰ 10:30–11:30 AM CET This webinar highlights work among several EU-funded projects, including the LETHE Project, The AI-Mind Project, the ADIS JPND project and the IHI-PROMINENT. 🧠 Don't miss this opportunity to explore how AI transforms dementia prevention, diagnosis, and treatment, including an insightful talk from Ainar Drews (AI-Mind, University of Oslo). 👉 Register now and be part of the conversation! https://shorturl.at/uI0zV #dementiaresearch #Horizon2020 #webinar #collaboration #research

We’re pleased to join the third event of the LETHE webinar series: Beyond the hype: AI in dementia – from early risk detection to disease treatment. This webinar, taking place on 17 January from 10.30-11.30am CET, will showcase the work of several EU-funded projects – LETHE, AI-Mind, ADIS, and PROMINENT – exploring how AI is being applied across different stages of dementia research, from prevention and early diagnosis to intervention and treatment. Speakers include: 🔹 Markus Bödenler (LETHE Project, FH Joanneum) on AI in dementia prevention and risk assessment. 🔹 Ainar Drews (The AI-Mind Project, University of Oslo) on tools for early risk detection of cognitive decline. 🔹 Sophia Krix (ADIS JPND, Fraunhofer SCAI) on earlier Alzheimer’s diagnosis through immune cell profiling and sleep analysis. 🔹 Antti Tolonen (IHI-PROMINENT, Combinostics) on AI and machine learning for advancing precision medicine in neurodegeneration. 🔗 Register here: https://lnkd.in/dJTF4hVj All of this work is possible, thanks to #H2020 funding, including through the JPND - EU Joint-Programme Neurodegenerative Disease Research & Innovative Health Initiative (IHI)

We are pleased to announce the third LETHE Project webinar: "Beyond the hype: AI in dementia – from early risk detection to disease treatment." Join us on 17 January from 10.30-11.30am CET with The AI-Mind Project (Ainar Drews from Oslo University Hospital), ADIS JPND (Sophia Krix from Fraunhofer SCAI) & IHI-PROMINENT (Antti Tolonen from Combinostics) to explore how AI is being applied in European research to address prevention, early diagnosis & intervention in dementia. Register now and be part of the discussion! Innovative Health Initiative (IHI) JPND - EU Joint-Programme Neurodegenerative Disease Research #H2020 Hannes Hilberger Jon Switters Sten Hanke Ira Hebold Haraldsen Holger Fröhlich Linus Jönsson https://lnkd.in/ehbFFV_z

EU cannot afford to stand by while the rest of the world is making progress. Doing nothing is not an option. Now, more than ever, is the time to invest in research. To make sure that together, we are moving towards a future with personalized medicine for Alzheimer’s disease. This was the main message of my presentation at the Lunch Debate, organized by Alzheimer Europe at the European Parliament today. #Alzheimer and #dementia are among the largest healthcare challenges of our century. Yet there is hope, because innovations in diagnosis, prediction, prevention, and treatment for this disease develop at a rapid pace. Heartwarming, to see the huge turn-up, of members of parliament, national representatives, patients and caregivers, national Alzheimer associations, and many others. Because together, we can make a difference! Kudos to the team at Alzheimer Europe for organizing this #AELunchDebate Jean Georges Cristina Pencea Angela Bradshaw Cindy Birck Tilly Metz Niklas Blomberg catherine berens Marco Blom Conny Helder Francesca Mangialasche Alzheimer Nederland AD-RIDDLE IHI-PROMINENT Multi-MeMo EU FINGERS JPND - EU Joint-Programme Neurodegenerative Disease Research Innovative Health Initiative (IHI) #aboardproject ZonMw Health~Holland Amsterdam UMC - Alzheimercentrum Amsterdam

A busy day for AD-RIDDLE in Brussels! 🇧🇪 🇪🇺 Yesterday, we were delighted to join the European #dementia community at the European Parliament, where our partners Alzheimer Europe organised their first #European Dementia Day. This day was the culmination of the NGO’s 2024 #DementiaNeedsEU campaign, calling for dementia to be a policy and research priority🚨 📍 Our partners Francesca Mangialasche & Wiesje van der Flier joined over 100 representatives of national #Alzheimer Associations and people with lived experience of dementia, as well as MEPs and research policymakers at a Lunch Debate on "Dementia as a Research Priority". 🗣️ Niklas Blomberg, Executive Director of the Innovative Health Initiative (IHI), explained how public-private partnerships are driving patient-centered innovations, highlighting AD-RIDDLE amongst other #neurodegeneration research projects including European Platform for Neurodegenerative Diseases (EPND), IHI-PROMINENT and PREDICTOM - IHI project 💪 🗣️ Wiesje van der Flier, who leads our #digital cognitive assessment workstream, shared how innovations in diagnosis, prediction and treatment for #Alzheimers disease are rapidly progressing, highlighting initiatives such as #ABOARD, WW-FINGERS and AD-RIDDLE that are moving the field towards personalised prevention and care 🏥 🤝 After the Lunch Debate, Francesca Mangialasche met with representatives of over 20 European #Alzheimer associations to discuss the what, why and how of AD-RIDDLE. Together with our #PublicInvolvement activities, workshops such as these are helping us to shape the AD-RIDDLE toolbox platform to meet the needs of people with or at risk of Alzheimer's disease, as well as the organisations that support them 💜 Want to learn more? Keep your eyes peeled for the launch of our first e-Newsletter, in January! 🚀 Innovative Health Initiative (IHI) EFPIA - European Federation of Pharmaceutical Industries and Associations EuropaBio - the European Association for Bioindustries MedTech Europe Vaccines Europe COCIR Amsterdam UMC - Alzheimer Center Amsterdam Karolinska Institutet FINGERS Brain Health Institute

Today’s #AELunchDebate, hosted by Alzheimer Europe, brought together a diverse group of stakeholders in Brussels, including members of the European Parliament, people living with dementia, carers, national Alzheimer’s organisations, researchers, academics and industry representatives. MEP Tilly Metz from Luxembourg kicked off the event by welcoming all delegates to an inspiring event discussing the importance of dementia research as a European priority and exploring the latest advancements and the future in the field. The first speaker, Wiesje van der Flier from Amsterdam UMC, provided a compelling update on the latest progress in the field of prevention, diagnosis and treatment of #Alzheimer’s disease and other types of dementia. Her insights into the AD-RIDDLE, IHI-PROMINENT, Multi-MeMo and EU FINGERS projects highlighted the importance of collaboration to address this global health challenge. A heartfelt thank you to Niklas Blomberg, Executive Director of Innovative Health Initiative (IHI), who shared key insights into the research projects funded by IMI and IHI. He outlined crucial projects where Alzheimer Europe is collaborating, emphasising the power of partnerships in advancing dementia research and highlighting the importance of #PublicInvolvement. We also heard from Catherine Berens (DG Research and Innovation, European Commission), presenting on the European Partnership for Brain Health and its focus to making #Dementia a research priority in European research. Following these three impactful presentations, a lively discussion took place between attendees and members of the European Alzheimer’s Alliance in attendance. Alzheimer Europe has strived to make dementia a political priority at a European level. Let’s continue to build on this momentum and work together! #collaboration #DementiaNeedsEU #BrainHealth

❄️ Winter is coming, and IHI and IMI's projects are continuing to deliver ⛄ Here's a round-up of what our projects got up to in November: 🤰 IMI ConcePTION launched their Meds4Mums2B mobile app: https://lnkd.in/dpH3V8kM 🦠 RespiriTB launched a Phase 1 clinical trial into a new injectable treatment for #TB #TBresearch: https://lnkd.in/ee_CWfQQ 🚸 conect4children is looking for new participants for its CDISC Paediatrics User Network: https://lnkd.in/g7dWi_HG 📚 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 😷 The CARE Consortium found that a combination of 3 antiviral drugs could help inhibit #Coronavirus replication: https://lnkd.in/esC_daN3 💾 IHI-PROMINENT published a paper on how a data-driven approach can influence dementia diagnostics: https://lnkd.in/eqCw5sHy 🧠 AMYPAD published guidelines for using the Centiloid scale to measure amyloid plaques in the brains of #Alzheimer's patients: https://lnkd.in/eVnDCcun 👀 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐛𝐚𝐜𝐤 👩💻 IMI_EHDEN published a booklet charting the project's journey https://bit.ly/3V5BEHB 📺 Watch this interview with VALUE-Dx's coordinator about the project's main achievements #AMR: https://lnkd.in/eRzPc5SQ 🙋 EUPATI interviewed some of their programme fellows to develop this video #PatientEducation: https://lnkd.in/ez9ZFQNM #IHITransformingHealth #HorizonEU #HealthResearch